Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Feb 22, 2021 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 55,711 | -- | 558,680 |
Feb 22, 2021 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 32,734 | $7.59 | 525,946 |
Feb 17, 2021 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 136,842 | -- | 502,969 |
Feb 20, 2020 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 60,963 | -- | 396,509 |
Feb 20, 2020 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 30,382 | $17.21 | 366,127 |
Feb 19, 2020 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 62,053 | $16.76 | 335,546 |
Mar 01, 2019 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 21,251 | $20.69 | 273,493 |
Feb 25, 2019 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 33,071 | -- | 306,564 |
Feb 25, 2019 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 11,820 | $21.97 | 294,744 |
Feb 20, 2019 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 48,735 | $21.34 | 273,493 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.